| 摘要 |
Compound of formula I: or formula II, or a pharmaceutically acceptable salt of formula I or formula II, wherein: R1 is H, hydroxyl, alkoxy, acyl, alkyl, cycloalkyl, aryl, or heteroaryl; R2 is methyl, haloalkyl, or heteroaryl; R4 is hydroxyl, carbonyloxy, or carbonyldioxy; R5, R6, R7 and R8 are each individually H, halogen, alkoxy, alkyl, haloalkyl, aryl, nitro, cyano, amino, amido, acyl, carboxyl, substituted carboxyl, or -SO2R10, wherein R10 is H, alkyl, amino or haloalkyl; and R3 is |
| 申请人 |
RISCOE, MICHAEL, K.;KELLY, JANE, X.;WINTER, ROLF, W.;HINRICHS, DAVID, J.;SMILKSTEIN, MARTIN, J.;NILSEN, AARON;MEDICINES FOR MALARIA VENTURE;UNIVERSITY OF SOUTH FLORIDA;BURROWS, JEREMY;KYLE, DENNIS;MANETSCH, ROMAN;CROSS, RICHARD, M.;MONASTYRSKYI, ANDRII;FLANIGAN, DAVID, L.;OREGON HEALTH & SCIENCE UNIVERSITY;THE GOVERNMENT OF THE UNITED STATES OF AMERICA DBA THE DEPARTMENT OF VETERANS AFFAIRS |
发明人 |
RISCOE, MICHAEL, K.;KELLY, JANE, X.;WINTER, ROLF, W.;HINRICHS, DAVID, J.;SMILKSTEIN, MARTIN, J.;NILSEN, AARON;BURROWS, JEREMY;KYLE, DENNIS;MANETSCH, ROMAN;CROSS, RICHARD, M.;MONASTYRSKYI, ANDRII;FLANIGAN, DAVID, L. |
